Loading
Latest filing published 30 Jun 2022 for 千红制药, €2.9M.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
王轲 is a declared insider of 千红制药 (chief executive), with filings sourced from SSE / SZSE (CSRC). Over a trading history stretching from 29 June 2022 to 30 June 2022, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €10.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 30 June 2022, the filings show an open-market purchase worth €2.9M in 千红制药. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.